Results 121 to 130 of about 18,069 (179)
Haemophilus b conjugate vaccine.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1988 openaire +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Veterinary Immunology and Immunopathology, 2016
Glässer's disease, which is caused by Haemophilus parasuis, is a major threat to swine throughout the world. At present, the predominant method of controlling this disease is through vaccination with an inactivated vaccine, which has many limitations. For example, there is no available method to differentiate between infected and vaccinated animals. In
Huisheng Liu +3 more
openaire +2 more sources
Glässer's disease, which is caused by Haemophilus parasuis, is a major threat to swine throughout the world. At present, the predominant method of controlling this disease is through vaccination with an inactivated vaccine, which has many limitations. For example, there is no available method to differentiate between infected and vaccinated animals. In
Huisheng Liu +3 more
openaire +2 more sources
Haemophilus b Disease After Vaccination With Haemophilus b Polysaccharide or Conjugate Vaccine
Archives of Pediatrics & Adolescent Medicine, 1991The reported frequency of invasive Haemophilus influenzae type b disease occurring within 1 year after immunization was compared in American children who received either Praxis Biologics' Haemophilus b polysaccharide vaccine or Connaught Laboratories' Haemophilus b conjugate vaccine during the first year of distribution.
C E, Frasch, E E, Hiner, T P, Gross
openaire +2 more sources
Haemophilus influenzae Vaccine
Pediatrics, 1986The primary advice from both the Committee on Infectious Diseases of the American Academy of Pediatrics1 and the Immunization Practices Advisory Committee2 is to recommend that a newly licensed vaccine against Haemophilus influenzae type b should be given to all children at 24 months of age.
openaire +2 more sources
The Journal of Pediatrics, 1993
The incidence of invasive Haemophilus disease has unexpectedly decreased in unvaccinated children since the introduction of conjugate vaccine in the United States. The purpose of this study was to determine whether conjugate vaccination decreases colonization with Haemophilus influenzae type b.This study was a prospective, bimonthly survey of ...
T V, Murphy +4 more
openaire +2 more sources
The incidence of invasive Haemophilus disease has unexpectedly decreased in unvaccinated children since the introduction of conjugate vaccine in the United States. The purpose of this study was to determine whether conjugate vaccination decreases colonization with Haemophilus influenzae type b.This study was a prospective, bimonthly survey of ...
T V, Murphy +4 more
openaire +2 more sources
Haemophilus influenzae b-vaccination: the urgency for timely vaccination
European Journal of Pediatrics, 1997In Germany the annual number of systemic Haemophilus influenzae cases in unvaccinated children aged 3-60 months has recently been exceeded by the number of cases in children vaccinated at least once with the PRP-D, HbOC or OMP vaccines, which until 1995 have almost exclusively been used for H. influenzae b (Hib) vaccination.
R, von Kries, O, Böhm, A, Windfuhr
openaire +2 more sources
Evaluation of Pasteurella and Haemophilus Vaccines
American Association of Bovine Practitioners Conference Proceedings, 1994The family Pasteurellaceae Pohl contains gramnegative, facultatively anaerobic and fermentative bacteria of the genera Pasteurella, Haemophilus, and Actinobacillus. Of these genera, Haemophilus somnus, Pasteurella multocida and Pasteurella haemolytica are prominent pathogens in domestic cattle causing severe diseases and major economic losses ...
Confer, Anthony W., Fulton, Robert W.
openaire +1 more source
Third Vaccine for Haemophilus influenzae?
JAMA: The Journal of the American Medical Association, 1991THE WAY has been opened to license a third vaccine againstHaemophilus influenzaefor use in 2-month-old infants. Pasteur Merieux, Swiftwater, Pa, the manufacturer of the third vaccine, was in the midst of two double-blind, placebo-controlled studies a year ago when the Food and Drug Administration (FDA) licensed a vaccine againstH influenzaeto Lederle ...
openaire +1 more source